{"disease":{"id":"high-risk-resectable-nsclc","name":"high risk resectable nsclc"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03732664","title":"ICIs Neoadjuvant Therapy in Resectable Non-Small-Cell Lung Cancer","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":27,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}